Clinical Trial Update: Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of butylphthalide for Multiple System Atrophy is listed as Phase 2/Phase 3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Multiple System Atrophy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING